Sorafenib increases cytochrome P450 lipid metabolites in patient with hepatocellular carcinoma.

Front Pharmacol · 2023 · PMC10020374 · PMID 36937889

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

failed to reach significanceno p-value reported

Levels of epoxymetabolites derived from the n-3 PUFAs tended to increase as well, but for DHA- and EPA-derived epoxides failed to reach significance ( Figures 2A–C ; Supplementary Figures S1A–C ).

also in 4,113 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.